The photosensitising properties of the antihypertensive drug hydrochlorothiazide increase the risk of skin cancers on sun-exposed areas of skin, a study from the University of NSW Sydney has shown. Researchers at the university’s Centre for Big Data Research in Health aimed to determine the risk of lip cancer and malignant melanoma among Australians prescribed hydrochlorothiazide. ...
Photosensitising effects of hydrochlorothiazide raise skin cancer risk
7 Aug 2020